On June 17, Creso Pharma and Red Light Holland entered into a definitive agreement to merge their businesses and create The HighBrid Lab.
Psychedelics entrepreneur Bruce Linton, current Red Light Holland CEO Todd Shapiro, Creso Pharma Non-Executive Chairman Adam Blumenthal and newly-appointed Highbrid Lab Executive Vice President William Lay present the merged entity’s latest investor presentation.
—————————————————————————————————————————————————————
InvestorStream
Find out more about us: investorstream.com.au
Like us on Facebook: bit.ly/FBInvestorStream
Follow us on Twitter: twitter.com/InvestorStream_
Follow us on LinkedIn: linkedin.com/company/investorstream
source